Steven T. Rosen
- Dermatology top 0.05%
- Cutaneous lymphoproliferative disorders research 114
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 150
- Oncology top 0.2%
- CAR-T cell therapy research 49
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 58
- Immunology top 0.5%
- T-cell and Retrovirus Studies 50
-
- Monoclonal and Polyclonal Antibodies Research 42
-
- Multiple Myeloma Research and Treatments 29
-
- Glycosylation and Glycoproteins Research 17
- Co-authors
- Nancy KrettJoan GuitartTimothy M. KuzelChristiane QuerfeldRandy D. GascoyneKensei TobinaiJulie M. VoseRichard T. Hoppe
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Journal of the American Chemical Society (2 papers)JAMA (1 paper)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
Steven T. Rosen
408 papers receiving 15.6k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Dermatology 3.2k
- Pathology and Forensic Medicine 6.5k
- Oncology 5.7k
- Genetics 1.9k
- Immunology 3.3k
Countries citing papers authored by Steven T. Rosen
This map shows the geographic impact of Steven T. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven T. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven T. Rosen more than expected).
Fields of papers citing papers by Steven T. Rosen
This network shows the impact of papers produced by Steven T. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven T. Rosen. The network helps show where Steven T. Rosen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steven T. Rosen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 14 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 61 | |
| 12 | 2018 | 74 | |
| 13 | 2018 | 18 | |
| 14 | 2017 | 2 | |
| 15 | 2017 | 0 | |
| 16 | 2014 | 123 | |
| 17 | 2009 | 15 | |
| 18 | T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirusbreakdown → | 2008 | 550 |
| 19 | 2006 | 31 | |
| 20 | A monoclonal antibody (ma) which distinguished human small cell lung cancer (sclc) from other lung cancer types. Abstr. | 1981 | 2 |
About Steven T. Rosen
Steven T. Rosen is a scholar working on Dermatology, Pathology and Forensic Medicine and Oncology, having authored 423 papers that have together received 15.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (150 papers), Cutaneous lymphoproliferative disorders research (114 papers), Chronic Lymphocytic Leukemia Research (58 papers), T-cell and Retrovirus Studies (50 papers), CAR-T cell therapy research (49 papers), Monoclonal and Polyclonal Antibodies Research (42 papers), Multiple Myeloma Research and Treatments (29 papers) and Glycosylation and Glycoproteins Research (17 papers). The work is most often cited by research in Dermatology (3.2k citations), Pathology and Forensic Medicine (6.5k citations) and Oncology (5.7k citations). Steven T. Rosen has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Nancy Krett, Joan Guitart, Timothy M. Kuzel, Christiane Querfeld, Randy D. Gascoyne, Kensei Tobinai, Julie M. Vose, Richard T. Hoppe, Mala Shanmugam and Sigrid Stroobants. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.